Back to SPRY overview

SPRY ARS Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio of SPRY cannot be calculated, as the latest EPS of -$0.52 is negative. The most recent PE ratio recorded for ARS Pharmaceuticals was 9.96 in September 2022.

SPRY PE ratio history

How has SPRY's PE ratio performed in the past

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

ARS Pharmaceuticals PE ratio by year

Year	PE ratio	Change
2023	N/A	N/A
2022	N/A	N/A
2021	N/A	N/A
2020	N/A	N/A
2019	N/A	N/A
2018	N/A	N/A

SPRY average PE ratio chart

What is the average PE ratio of SPRY for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

SPRY PE vs peers

What is SPRY's PE ratio compared to its peers

Stock name	PE ratio	Market cap
OMER Omeros Corp	N/A	$199.91M
OMGA Omega Therapeutics Inc	N/A	$132.92M
SPRY ARS Pharmaceuticals Inc	N/A	$874.96M

Frequently asked questions

What is ARS Pharmaceuticals's PE ratio?

The current price to earnings ratio of SPRY cannot be determined, as its EPS of -$0.52 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.